Pancreatic Cancer Research

ResearcherNational Cheng Kung UniversityActive in the last 2 years

Pei-Chia Su

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-0861-9023; OpenAlex author ID A5050791626. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

  1. Stromal CCL2/CXCL10/SPARC axes drive pro-tumor CHI3L1 expression for microenvironmental modulation in pancreatic cancer progression and therapeutic innovation. Co-author DOI 10.1186/s12929-026-01295-2↗
  2. Macrophage activation determines muscle wasting in pancreatic cancer. Co-author DOI 10.1038/s41388-025-03434-9↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ya‐Chin Hou · 2 shared papers, 2025–2026 · strength 0.56
  2. Yi‐Ching Wang · 2 shared papers, 2025–2026 · strength 0.56
  3. Yan-Shen Shan · 1 shared paper, 2026 · strength 0.36
  4. Po-Hsien Huang · 1 shared paper, 2025 · strength 0.20
  5. Szu-Ying Chen · 1 shared paper, 2025 · strength 0.20
  6. Chih‐Han Chang · 1 shared paper, 2025 · strength 0.20
  7. Li-Yun Ding · 1 shared paper, 2025 · strength 0.20
  8. Yan‐Shen Shan · 1 shared paper, 2025 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.